Chemotherapy with mitoxantrone lus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomised trial with palliative end points. - Tannock,I.F.; Osoba,D.; Stockler,M.R. (J Clin Oncol, 1996)